DLocal Limited (DLO) shares experienced a significant surge in today’s pre-market trading session, fueled by the company’s better-than-expected third-quarter revenue results. Despite exceeding analysts’ revenue forecasts, DLocal fell short on earnings, reporting quarterly earnings of 9 cents per share, missing the consensus estimate of 11 cents per share.
The company announced quarterly sales of $185.774 million, surpassing the analyst consensus estimate of $181.463 million. This positive revenue performance drove DLocal shares up by an impressive 18.3%, reaching $10.70 in the pre-market trading session.
Beyond DLocal, several other stocks were making notable moves in the pre-market:
Gainers:
*
Elevai Labs Inc. (ELAB):
The stock gained a substantial 91.1% to $0.0472 in pre-market trading, following a 32% surge on Wednesday.*
SRIVARU Holding Limited (SVMH):
This stock climbed by 40% to $0.0339 in pre-market trading.*
XTI Aerospace, Inc. (XTIA):
XTIA gained 35.7% to $0.0777 in pre-market trading, building upon an 18% increase on Wednesday.*
Nuburu, Inc. (BURU):
The stock gained 28.7% to $0.5335 in pre-market trading.*
Zoomcar Holdings, Inc. (ZCAR):
This company’s stock saw a 26.9% jump to $8.25 in pre-market trading following the release of its second-quarter results.*
Quantum Computing Inc. (QUBT):
QUBT climbed 25.8% to $3.34 in pre-market trading, adding to its more than 92% increase on Wednesday.*
Zeta Global Holdings Corp. (ZETA):
ZETA gained 20.5% to $21.40 in pre-market trading, bolstered by the announcement of its expanded share repurchase program with a $100 million buyback authorization through 2026.*
1847 Holdings LLC (EFSH):
EFSH gained 17.7% to $0.5301 in pre-market trading after experiencing a 58% dip on Wednesday.*
D-Wave Quantum Inc. (QBTS):
QBTS gained 14.6% to $2.04 in pre-market trading.
Losers:
*
Calidi Biotherapeutics, Inc. (CLDI):
CLDI shares tumbled 27% to $2.47 in pre-market trading, influenced by the company’s announcement of a proposed public offering.*
Digital Brands Group, Inc. (DBGI):
DBGI shares fell 26.5% to $0.1329 in pre-market trading, following a jump of over 40% on Wednesday.*
Harrow, Inc. (HROW):
HROW declined 25.8% to $38.45 in pre-market trading after reporting disappointing third-quarter sales results.*
Ibotta, Inc. (IBTA):
IBTA shares fell 22.9% to $57.75 in pre-market trading following the release of its quarterly results.*
Cyclacel Pharmaceuticals, Inc. (CYCC):
CYCC fell 18.7% to $0.3658 in pre-market trading, after gaining around 10% on Wednesday.*
Bluejay Diagnostics, Inc. (BJDX):
BJDX dipped 18.3% to $0.0850 in pre-market trading following a 1-for-50 reverse stock split announcement.*
Matinas BioPharma Holdings, Inc. (MTNB):
MTNB shares dipped 15.9% to $0.5969 in pre-market trading, following a decline of around 5% on Wednesday.*
ESS Tech, Inc. (GWH):
GWH fell 13.8% to $7.68 in pre-market trading following its third-quarter results.*
Taysha Gene Therapies, Inc. (TSHA):
TSHA fell 10.8% to $1.9700 in pre-market trading following its third-quarter results.*
